150 related articles for article (PubMed ID: 35604130)
1. Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening.
Liberal V; Forrat R; Zhang C; Pan C; Bonaparte M; Yin W; Zheng L; Viscardi V; Wu Y; Ataman-Önal Y; Savarino S; Chen C
Microbiol Spectr; 2022 Jun; 10(3):e0071121. PubMed ID: 35604130
[TBL] [Abstract][Full Text] [Related]
2. Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with a new dengue rapid diagnostic test: a retrospective analysis of phase 3 efficacy trials.
Savarino SJ; Bonaparte M; Wang H; Dayan GH; Forrat R; Zhu M; Hodge S; Ataman-Önal Y; DiazGranados CA
Lancet Microbe; 2022 Jun; 3(6):e427-e434. PubMed ID: 35659904
[TBL] [Abstract][Full Text] [Related]
3. Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with five commercially available immunoassays: a retrospective analysis of phase 3 efficacy trials.
DiazGranados CA; Bonaparte M; Wang H; Zhu M; Lustig Y; Schwartz E; Forrat R; Dayan GH; Hodge S; Ataman-Önal Y; Savarino SJ
Lancet Infect Dis; 2021 Apr; 21(4):529-536. PubMed ID: 33212068
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection.
Bonaparte M; Zheng L; Garg S; Guy B; Lustig Y; Schwartz E; DiazGranados CA; Savarino S; Ataman-Önal Y
J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31616949
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of dengue serological tests available in Puerto Rico for identification of prior dengue infection for prevaccination screening.
Bonaparte M; Huleatt J; Hodge S; Zheng L; Lustig Y; DiazGranados CA; Ataman-Önal Y; Savarino S
Diagn Microbiol Infect Dis; 2020 Mar; 96(3):114918. PubMed ID: 31839333
[TBL] [Abstract][Full Text] [Related]
6. Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to dengue virus.
Nascimento EJM; George JK; Velasco M; Bonaparte MI; Zheng L; DiazGranados CA; Marques ETA; Huleatt JW
J Virol Methods; 2018 Jul; 257():48-57. PubMed ID: 29567514
[TBL] [Abstract][Full Text] [Related]
7. Field evaluation of rapid diagnostic tests to determine dengue serostatus in Timor-Leste.
Arkell P; Tanesi M; Gomes N; Joao JC; Oakley T; Bosco F; Yan J; Fancourt NSS; Francis JR
PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010877. PubMed ID: 36342959
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.
Coronel-MartÍnez DL; Park J; López-Medina E; Capeding MR; Cadena Bonfanti AA; Montalbán MC; Ramírez I; Gonzales MLA; DiazGranados CA; Zambrano B; Dayan G; Savarino S; Chen Z; Wang H; Sun S; Bonaparte M; Rojas A; Ramírez JC; Verdan MA; Noriega F
Lancet Infect Dis; 2021 Apr; 21(4):517-528. PubMed ID: 33212067
[TBL] [Abstract][Full Text] [Related]
9. Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews.
Luo R; Fongwen N; Kelly-Cirino C; Harris E; Wilder-Smith A; Peeling RW
Clin Microbiol Infect; 2019 Jun; 25(6):659-666. PubMed ID: 30664935
[TBL] [Abstract][Full Text] [Related]
10. Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
Plennevaux E; Moureau A; Arredondo-García JL; Villar L; Pitisuttithum P; Tran NH; Bonaparte M; Chansinghakul D; Coronel DL; L'Azou M; Ochiai RL; Toh ML; Noriega F; Bouckenooghe A
Clin Infect Dis; 2018 Apr; 66(8):1164-1172. PubMed ID: 29300876
[TBL] [Abstract][Full Text] [Related]
11. Adapting Rapid Diagnostic Tests to Detect Historical Dengue Virus Infections.
Echegaray F; Laing P; Hernandez S; Marquez S; Harris A; Laing I; Chambers A; McLennan N; Sugiharto VA; Chen HW; Villagran SV; Collingwood A; Montoya M; Carrillo FB; Simons MP; Cooper PJ; Lopez A; Trueba G; Eisenberg J; Wu SJ; Messer W; Harris E; Coloma J; Katzelnick LC
Front Immunol; 2021; 12():703887. PubMed ID: 34367162
[TBL] [Abstract][Full Text] [Related]
12. Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus.
Dayan GH; Langevin E; Forrat R; Zambrano B; Noriega F; Frago C; Bouckenooghe A; Machabert T; Savarino S; DiazGranados CA
Vaccine; 2020 Sep; 38(41):6472-6477. PubMed ID: 32773243
[TBL] [Abstract][Full Text] [Related]
13. CYD Tetravalent Dengue Vaccine Performance by Baseline Immune Profile (Monotypic/Multitypic) in Dengue-Seropositive Individuals.
DiazGranados CA; Langevin E; Bonaparte M; Sridhar S; Machabert T; Dayan G; Forrat R; Savarino S
Clin Infect Dis; 2021 May; 72(10):1730-1737. PubMed ID: 32198515
[TBL] [Abstract][Full Text] [Related]
14. Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report.
Wilder-Smith A; Smith PG; Luo R; Kelly-Cirino C; Curry D; Larson H; Durbin A; Chu M; Tharmaphornpilas P; Ng LC; Sartori AMC; Luna EJA; Gubler DJ; España G; Yoon IK; Flasche S
Vaccine; 2019 Aug; 37(36):5137-5146. PubMed ID: 31377079
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico's Universal Vaccination Program].
Hernández-Ávila M; Lazcano-Ponce E; Hernández-Ávila JE; Alpuche-Aranda CM; Rodríguez-López MH; García-García L; Madrid-Marina V; López Gatell-Ramírez H; Lanz-Mendoza H; Martínez-Barnetche J; Díaz-Ortega JL; Ángeles-Llerenas A; Barrientos-Gutiérrez T; Bautista-Arredondo S; Santos-Preciado JI
Salud Publica Mex; 2016; 58(1):71-83. PubMed ID: 26879510
[TBL] [Abstract][Full Text] [Related]
16. Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction.
Plennevaux E; Sabchareon A; Limkittikul K; Chanthavanich P; Sirivichayakul C; Moureau A; Boaz M; Wartel TA; Saville M; Bouckenooghe A
Vaccine; 2016 May; 34(24):2707-12. PubMed ID: 27102820
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of one versus two doses of Takeda's tetravalent dengue vaccine in children in Asia and Latin America: interim results from a phase 2, randomised, placebo-controlled study.
Sáez-Llorens X; Tricou V; Yu D; Rivera L; Tuboi S; Garbes P; Borkowski A; Wallace D
Lancet Infect Dis; 2017 Jun; 17(6):615-625. PubMed ID: 28365225
[TBL] [Abstract][Full Text] [Related]
18. Public health impact and cost-effectiveness of implementing a 'pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico.
Thommes E; Coudeville L; Muhammad R; Martin M; Nelson CB; Chit A
Vaccine; 2022 Nov; 40(50):7343-7351. PubMed ID: 36347720
[TBL] [Abstract][Full Text] [Related]
19. Target product profile for a dengue pre-vaccination screening test.
Fongwen N; Wilder-Smith A; Gubler DJ; Ooi EE; T Salvana EM; de Lamballerie X; Olliaro PL; Peeling RW
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009557. PubMed ID: 34324505
[TBL] [Abstract][Full Text] [Related]
20. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study.
Lopez AL; Adams C; Ylade M; Jadi R; Daag JV; Molloy CT; Agrupis KA; Kim DR; Silva MW; Yoon IK; White L; Deen J; de Silva AM
Lancet Glob Health; 2021 Jan; 9(1):e44-e51. PubMed ID: 33212030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
